Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CACNA1I |
| Upstream (Parents) |
|---|
| (<<) AKT2 → CACNA1I |
| (<<) ALPP → CACNA1I |
| (<<) CAMKK2 → CACNA1I |
| (<<) FLJ22184 → CACNA1I |
| (<<) GNB5 → CACNA1I |
| (<<) GSK3A → CACNA1I |
| (<<) IL1RN → CACNA1I |
| (<<) MAP3K12 → CACNA1I |
| (<<) MAP6D1 → CACNA1I |
| (<<) PIK3C3 → CACNA1I |
| (<<) PLA2G6 → CACNA1I |
| (<<) RAB5B → CACNA1I |
| (<<) SOX2 → CACNA1I |
| Downstream (Children) |
|---|
| CACNA1I → CDK6 (>>) |
| CACNA1I → EMILIN2 (>>) |
| CACNA1I → MEF2D (>>) |
| CACNA1I → MRAS (>>) |
| CACNA1I → TUBA8 (>>) |
